Which of the following is the MOST commonly observed...

Which of the following is the MOST commonly observed abnormality in patients with DIC?
(A) Prolonged prothrombin time.
(B) Thrombocytopenia.
(C) Hypofibrinogenemia.
(D) Elevated fibrin degradation products and D-dimer assay.

Key Concepts

Laboratory Markers in Coagulopathies

Various laboratory tests are used to assess coagulation status and diagnose bleeding disorders. Key markers include prothrombin time (PT), platelet count, fibrinogen levels, and the presence of fibrin degradation products. In the context of DIC, these tests help in determining the extent of coagulation factor consumption and fibrinolysis, guiding appropriate clinical management.

Fibrinolysis and Fibrin Degradation Products

Fibrinolysis is the process by which the body breaks down clots through the action of enzymes like plasmin. This breakdown results in the production of fibrin degradation products, including D-dimers. These elevated markers are significant in diagnosing conditions with increased clot formation and breakdown, such as DIC, where they are commonly found to be raised.

Disseminated Intravascular Coagulation (DIC)

DIC is an acquired disorder characterized by widespread activation of the blood clotting cascade, which results in the formation of microthrombi throughout the vasculature. This process consumes platelets and coagulation factors, often leading to bleeding complications due to the simultaneous occurrence of clotting and hemorrhage. It is commonly a secondary condition that can complicate various underlying diseases or severe infections.

Coagulation Cascade

The coagulation cascade is a series of enzymatic reactions that lead to blood clot formation. In normal hemostasis, the cascade is tightly regulated; however, in conditions like DIC, systemic activation of the cascade leads to excessive clot formation and subsequent consumption of clotting factors, which disrupts normal blood coagulation.

Please give Ace some feedback